Science Explorer Interactive view Map
Company · Wellesley · United States

Advanced Immune Therapeutics (United States)

Research works
3
▼ 100% vs 2013–17
Citations
115
39.0 per fractional work
Top-10% rate
11.5%
record average 16.5%
Open access
17%
world 28%

Not ranked overall: Advanced Immune Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Advanced Immune Therapeutics (United States) publish most on?

By volume: Immunotherapy and Immune Responses, Glycosylation and Glycoproteins Research, Immune Response and Inflammation and Cancer Research and Treatments.

  1. 1 Immunotherapy and Immune Responses Immunology 1 works
  2. 2 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  3. 3 Immune Response and Inflammation Immunology 0 works
  4. 4 Cancer Research and Treatments Biotechnology 0 works
  5. 5 Immune Cell Function and Interaction Immunology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Mast cells and histamine Immunology 0 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
  9. 9 PARP inhibition in cancer therapy Oncology 0 works
  10. 10 T-cell and B-cell Immunology Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available16.9%not open83.1%

World: 28% of research is openly available.

with international co-authors12.2%domestic only87.8%

World: 19% is written across borders.

How has Advanced Immune Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 100% lower than in 2013–2017.

20102015

Other research institutions in Wellesley

All research institutions in Wellesley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.